Literature DB >> 7587970

Cytokine levels in acute alcoholic hepatitis: a sequential study.

E Rodríguez-Rodríguez1, E González-Reimers, F Santolaria-Fernández, A Milena-Abril, F Rodríguez-Moreno, J Oramas-Rodríguez, A Martínez-Riera.   

Abstract

Chronic alcoholic liver disease is associated with several immunological alterations: depressed T-cell function, low serum gamma-interferon, and high serum tumour necrosis factor (TNF-alpha) and interleukin levels. Therefore, macrophage activity seems to be enhanced. Some cytokines, such as TNF-alpha, exert adverse effects on chronic alcoholic liver disease, so that protracted activation of macrophages with continuous TNF-alpha production may aggravate alcoholic hepatitis. Based on these facts we have sequentially determined serum levels of TNF-alpha, 1 beta interleukin (IL-1 beta), gamma-interferon and neopterin--a macrophage product--at admission, and at the end of the first, third and sixth weeks after admission, of 43 patients affected by alcoholic hepatitis, and of 20 age-matched sanitary workers as controls. Our patients showed higher levels of neopterin and lower levels of IL-1 beta and gamma-interferon than the controls; TNF-alpha levels in our patients were almost significantly higher than in controls. TNF-alpha levels at admission were higher in the patients who died (P = 0.025). TNF-alpha and neopterin levels showed no trend to normalization in patients who died, with higher levels of neopterin at first and third weeks and higher TNF-alpha and gamma-interferon levels at first week. Using logistic regression analysis, serum TNF-alpha levels at admission showed significant (P = 0.045), independent effects on mortality, as well as serum neopterin (P = 0.0026) at the first week. Thus, enhanced macrophage activity, measured by serum levels of TNF-alpha and neopterin seems to be related to a worse prognosis in alcoholic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7587970     DOI: 10.1016/0376-8716(95)01130-q

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  4 in total

Review 1.  Current concepts and controversies in the treatment of alcoholic hepatitis.

Authors:  Catherine Rongey; Neil Kaplowitz
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

Review 2.  Pathogenesis of alcoholic liver disease: role of oxidative metabolism.

Authors:  Elisabetta Ceni; Tommaso Mello; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 3.  Molecular targets in the treatment of alcoholic hepatitis.

Authors:  Ashwin D Dhanda; Richard Wl Lee; Peter L Collins; C Anne McCune
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

4.  Small heterodimer partner deficiency exacerbates binge drinking‑induced liver injury via modulation of natural killer T cell and neutrophil infiltration.

Authors:  Min-Jeong Go; Jung-Ran Noh; Jung Hwan Hwang; Kyoung-Shim Kim; Dong-Hee Choi; Jong-Soo Lee; Yong-Hoon Kim; Chul-Ho Lee
Journal:  Mol Med Rep       Date:  2018-01-26       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.